A new study has conducted a comprehensive exome and transcriptome analysis of a large number of intrahepatic, perihilar and distal cholangiocarcinomas and gallbladder cancers in Japanese patients. This study identifies many new alterations, confirms genetic differences in these distinct subtypes of biliary tract cancer and demonstrates that approximately 40% of described genetic aberrations are potentially targetable.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma – correlation with clinicopathological data and comparison of antibodies
BMC Cancer Open Access 15 January 2019
-
Emerging role of precision medicine in biliary tract cancers
npj Precision Oncology Open Access 03 October 2018
-
Guided chemotherapy based on patient‐derived mini‐xenograft models improves survival of gallbladder carcinoma patients
Cancer Communications Open Access 17 July 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Razumilava, N. & Gores, G.J. Lancet 383, 2168–2179 (2014).
Sia, D. et al. Gastroenterology 144, 829–840 (2013).
Homayounfar, K. et al. Hum. Pathol. 40, 834–842 (2009).
Ong, C.K. et al. Nat. Genet. 44, 690–693 (2012).
Churi, C.R. et al. PLoS ONE 9, e115383 (2014).
Arai, Y. et al. Hepatology 59, 1427–1434 (2014).
Nakamura, H. et al. Nat. Genet. 47, 1003–1010 (2015).
Wu, Y.M. et al. Cancer Discov. 3, 636–647 (2013).
Borad, M.J. et al. PLoS Genet. 10, e1004135 (2014).
Honeyman, J.N. et al. Science 343, 1010–1014 (2014).
Nault, J.C. et al. Nat. Commun. 4, 2218 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Razumilava, N., Gores, G. Building a staircase to precision medicine for biliary tract cancer. Nat Genet 47, 967–968 (2015). https://doi.org/10.1038/ng.3386
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.3386